Yasutaka Watanabe

机构：Saitama Cancer Center · ORCID：0000-0002-3679-4864

发表论文 75 篇 · 总被引 1839 次 · h-index 15

代表论文

• Perioperative Nivolumab in Resectable Lung Cancer (2024 · New England Journal of Medicine · 被引 517)
• Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study (2024 · Journal of Clinical Oncology · 被引 132)
• Hypercapnic tumor microenvironment confers chemoresistance to lung cancer cells by reprogramming mitochondrial metabolism in vitro (2019 · Free Radical Biology and Medicine · 被引 44)
• Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis (2018 · Internal Medicine · 被引 41)
• A clinicopathological study of surgically resected lung cancer in patients with usual interstitial pneumonia (2017 · Respiratory Medicine · 被引 29)
• Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer ( IMpower010 ) (2022 · Cancer Science · 被引 22)